HeartBeam, Inc. (BEAT:NASDAQ) closed at $0.393 on October 23, 2026, down 1.70% on the day. The stock trades 90.2% below its 52-week high of $4.00 and 10.8% above its 52-week low of $0.355. Over the past year, it lost 76.2%. HeartBeam, Inc. is part of the Health Care sector (Medical Specialities).
In 252 trading sessions since October 23, 2025, BEAT closed higher on 104 days (41%). Its best day was December 10, 2025 (+92.31%) and its worst was November 21, 2025 (-53.51%). The stock moved 10% or more in a single session 27 times. It opened at least 5% above the previous day's high 5 times.
BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The company operates in three segments: Healthcare, Research, and Technology. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. It offers Mobile Cardiac Outpatient Telemetry and External Cardiac Ambulatory Telemetry services, which incorporates a lightweight patient-worn sensor attached to electrodes that capture two-channel electrocardiography (ECG) data, measuring electrical activity of the heart, on a compact wireless handheld monitor; event monitoring services to prescribe wireless event monitors, digital loop event monitors, memory loop event monitors, and non-loop event monitors; and a Holter and extended-wear Holter monitors to cardiologists and electrophysiologists. The Research Services segment provides cardiac monitoring, imaging, scientific consulting, and data management services for drug, medical treatment, and device trials to pharmaceutical companies and contract research organizations. Its centralized services include ECG, Holter monitoring, ambulatory blood pressure...
Find more stocks like BEAT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.